1 | Alpha-tocotrienolquinone | - | - | - | - | 1件: 18 18 |
2 | Artesunate | 1件: Artesunate Artesunate | 1件: D02482
D02482
| - | - | 3件: 18 18, 66, 96 |
3 | Artesunate Oral Product | 1件: Artesunate Artesunate | 1件: D02482
D02482
| - | - | 1件: 18 18 |
4 | Baclofen | 1件: Baclofen Baclofen | 1件: D00241
D00241
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 |
5 | BINOCRIT*1SIR 40000UI/1ML | 1件: Erythropoietin Erythropoietin | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 18 18 |
6 | Bupropion | 1件: Bupropion Bupropion | 3件: D00817
D00817
,
D07591
,
D07938
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
7 | Bupropion & Citalopram | 2件: Bupropion Bupropion, Citalopram | 5件: D00817
D00817
,
D00822
,
D07591
,
D07704
,
D07938
| 3件: SLC6A2 SLC6A2, SLC6A3, SLC6A4 💬 | 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 18 18 |
8 | Butylphthalide | 1件: Butylphthalide Butylphthalide | - | - | - | 4件: 2 2, 6, 18, 22 |
9 | C-Trelin OD Tab(5mg Taltirelin Hydrate) | - | - | - | - | 1件: 18 18 |
10 | Cabaletta | 1件: Trehalose Trehalose | - | - | - | 2件: 18 18, 113 |
11 | Cabaletta for IV infusion once weekly during 24 weeks | 1件: Trehalose Trehalose | - | - | - | 1件: 18 18 |
12 | Calcitriol | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 18 18, 37, 46, 49, 66, 96, 158, 235, 326 |
13 | Carbonate | 1件: Carbonate ion Carbonate ion | - | - | - | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
14 | Citalopram | 1件: Citalopram Citalopram | 2件: D00822
D00822
,
D07704
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 7件: 6 6, 8, 13, 18, 46, 98, 127 |
15 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone | 1件: D01065
D01065
| - | - | 12件: 2 2, 5, 6, 8, 10, 18, 46, 57, 113, 193, 214, 215 |
16 | CTI-1601 | - | - | - | - | 1件: 18 18 |
17 | DEFERIPRONE | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
18 | Diagnostic Test: Blood analysis for hypercalcemia's control | - | - | - | - | 1件: 18 18 |
19 | DT-216 | - | - | - | - | 1件: 18 18 |
20 | EGB 761 (r) 120 mg | - | - | - | - | 1件: 18 18 |
21 | EGb 761 120 mg | - | - | - | - | 1件: 18 18 |
22 | Epoeitin beta | - | - | - | - | 1件: 18 18 |
23 | Epoetin alfa | 1件: Erythropoietin Erythropoietin | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 3件: 13 13, 18, 46 |
24 | EPREX*1FL 40000UI/ML 1ML | - | - | - | - | 1件: 18 18 |
25 | EPREX*1SIR 10000UI 1ML | - | - | - | - | 1件: 18 18 |
26 | EPREX*1SIR 40000UI/ML 1ML | - | - | - | - | 2件: 2 2, 18 |
27 | ERYTHROPOIETIN | 1件: Erythropoietin Erythropoietin | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 9件: 2 2, 6, 13, 18, 22, 47, 70, 95, 96 |
28 | ETRAVIRINA | 1件: Etravirine Etravirine | 1件: D04112
D04112
| - | - | 1件: 18 18 |
29 | Etravirine | 1件: Etravirine Etravirine | 1件: D04112
D04112
| - | - | 1件: 18 18 |
30 | Etravirine Tablets | 1件: Etravirine Etravirine | 1件: D04112
D04112
| - | - | 1件: 18 18 |
31 | EU1/97/031-032 | - | - | - | - | 1件: 18 18 |
32 | EU1/97/031/031-032 | - | - | - | - | 1件: 18 18 |
33 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
34 | Gamma interferon | - | - | - | - | 1件: 18 18 |
35 | Ginkgo | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 5件: 6 6, 13, 18, 47, 90 |
36 | Ginkgo biloba | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 4件: 13 13, 18, 47, 90 |
37 | Glentek 50 mg compresse rivestite con film | - | - | - | - | 1件: 18 18 |
38 | Glentek 50 mg film-coated tablets | - | - | - | - | 1件: 18 18 |
39 | Granocyte | - | - | - | - | 2件: 18 18, 57 |
40 | H-116PI-DE.pdf | - | - | - | - | 1件: 18 18 |
41 | High-dose intravenous immunoglobulin (IVIG) | - | - | - | - | 1件: 18 18 |
42 | Idebenone | 1件: Idebenone Idebenone | 1件: D01750
D01750
| - | - | 6件: 6 6, 8, 13, 18, 113, 302 |
43 | Imukin | - | - | - | - | 3件: 18 18, 58, 228 |
44 | IMUKIN - 6 FLACONI 0.5 ML 100 MCG | - | - | - | - | 2件: 18 18, 58 |
45 | IMUKIN*SC 6F 0,5ML 100MCG | - | - | - | - | 1件: 18 18 |
46 | INTELENCE | 1件: Etravirine Etravirine | 1件: D04112
D04112
| - | - | 1件: 18 18 |
47 | INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE | 1件: Etravirine Etravirine | 1件: D04112
D04112
| - | - | 1件: 18 18 |
48 | Interferon Gamma | 1件: Interferon Gamma Interferon Gamma | - | - | - | 8件: 18 18, 65, 85, 107, 228, 299, 301, 326 |
49 | INTERFERON GAMMA-1B | 2件: Interferon Gamma Interferon Gamma, Interferon gamma-1b | 1件: D00747
D00747
| 2件: IFNGR1 IFNGR1, IFNGR2 💬 | 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 7件: 18 18, 65, 85, 228, 299, 301, 326 |
50 | Iron | 1件: Iron Iron | - | - | - | 6件: 18 18, 96, 97, 238, 254, 284 |
51 | Iron chelating intervention | 1件: Iron Iron | - | - | - | 1件: 18 18 |
52 | J05AG04 | - | - | - | - | 1件: 18 18 |
53 | KPS-0373 | - | - | - | - | 1件: 18 18 |
54 | KPS-0373, High dose | - | - | - | - | 1件: 18 18 |
55 | KPS-0373, Low dose | - | - | - | - | 1件: 18 18 |
56 | Lenograstim | 1件: Lenograstim Lenograstim | 1件: D03247
D03247
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 7件: 2 2, 13, 16, 18, 19, 57, 65 |
57 | LITHIUM CARBONATE | 2件: Carbonate ion Carbonate ion, Lithium carbonate | 1件: D00801
D00801
| - | - | 6件: 2 2, 13, 17, 18, 19, 127 |
58 | Lu AA24493 | - | - | - | - | 1件: 18 18 |
59 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
60 | MIB-626 | - | - | - | - | 1件: 18 18 |
61 | MIN-102 | - | - | - | - | 2件: 18 18, 20 |
62 | Neo-Recormon | - | - | - | - | 1件: 18 18 |
63 | NeoRecormon | - | - | - | - | 2件: 13 13, 18 |
64 | Nicotinamide | 1件: Nicotinamide Nicotinamide | 1件: D00036
D00036
| - | - | 8件: 2 2, 6, 18, 49, 65, 107, 162, 191 |
65 | Nicotinamide riboside | 2件: Nicotinamide Nicotinamide, Nicotinamide riboside | 1件: D00036
D00036
| - | - | 4件: 2 2, 6, 18, 191 |
66 | Omaveloxolone | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
67 | Omaveloxolone Capsules, 10 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
68 | Omaveloxolone Capsules, 150 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
69 | Omaveloxolone Capsules, 160 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
70 | Omaveloxolone Capsules, 2.5 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
71 | Omaveloxolone Capsules, 20 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
72 | Omaveloxolone Capsules, 300 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
73 | Omaveloxolone Capsules, 40 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
74 | Omaveloxolone Capsules, 5 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
75 | Omaveloxolone Capsules, 80 mg | 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
76 | Other: Blood analysis for frataxin's level measurement | - | - | - | - | 1件: 18 18 |
77 | Other: Exercise intervention | - | - | - | - | 2件: 13 13, 18 |
78 | PTC743 | - | - | - | - | 2件: 18 18, 21 |
79 | Resveratrol | 1件: Resveratrol Resveratrol | - | - | - | 6件: 2 2, 8, 18, 89, 113, 299 |
80 | RHuG-CSF | - | - | - | - | 1件: 18 18 |
81 | RILUZOLE | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
82 | Riluzole PMCS | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 18 18 |
83 | RILUZOLO | - | - | - | - | 3件: 2 2, 18, 114 |
84 | Rokan (r) Novo 120 mg | - | - | - | - | 1件: 18 18 |
85 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
86 | Standardized Ginkgo Biloba Extract (EGb 761 (r) | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 1件: 18 18 |
87 | SUB09246MIG | - | - | - | - | 1件: 18 18 |
88 | TAK-831 | 1件: TAK-831 TAK-831 | - | - | - | 1件: 18 18 |
89 | VARENICLINE | 1件: Varenicline Varenicline | 1件: D08669
D08669
| 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 2件: 6 6, 18 |
90 | VATIQUINONE | 1件: Vatiquinone Vatiquinone | 1件: D10407
D10407
| - | - | 2件: 18 18, 21 |